Immediate Impact
50 standout
Citing Papers
The present and future of bispecific antibodies for cancer therapy
2024 Standout
DNA methylation in mammalian development and disease
2024 Standout
Works of Mark Tuthill being referenced
TRAIL-R2-specific antibodies and recombinant TRAIL can synergise to kill cancer cells
2014
DUSP16 is an epigenetically regulated determinant of JNK signalling in Burkitt's lymphoma
2010
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Mark Tuthill | 66 | 84 | 33 | 55 | 15 | 243 | |
| Feng Liu | 62 | 46 | 63 | 148 | 18 | 256 | |
| Liang Ren | 36 | 66 | 18 | 57 | 20 | 217 | |
| Martin Koch | 50 | 62 | 22 | 58 | 17 | 247 | |
| Hanjin Yang | 33 | 47 | 66 | 46 | 21 | 227 | |
| Andre M. Kallab | 27 | 62 | 65 | 88 | 17 | 278 | |
| Francesca Nesi | 25 | 30 | 35 | 58 | 17 | 285 | |
| Jennifer Furkel | 42 | 54 | 36 | 71 | 17 | 231 | |
| Eleonora Biasin | 15 | 45 | 33 | 41 | 20 | 217 | |
| Franca Sartor | 38 | 86 | 24 | 81 | 13 | 275 | |
| Koichi Udagawa | 32 | 60 | 38 | 36 | 15 | 251 |
All Works
Loading papers...